← Back to Search

Behavioral Intervention

Telerehabilitation for Low Vision (BeST-AID Trial)

N/A
Recruiting
Led By Ava K Bittner, OD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults with any level of vision loss due to any ocular disease who are age 18 and older
Be older than 18 years old
Must not have
Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner
Significant hearing loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month, 4 months, 8 months, 12 months, 13 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to use telerehabilitation to improve quality of life for people with low vision and to monitor when they stop using their devices.

Who is the study for?
This trial is for adults over 18 with any level of vision loss from ocular disease, who've just received new magnification devices or visual assistive apps. It's not for those with conflicting schedules, substance abuse issues, severe hearing loss, major health conditions limiting participation or lifespan, communication difficulties regarding visual stimuli, need other low vision training, or have incompatible device features.
What is being tested?
The study compares telerehabilitation to in-office care for follow-up training on using magnification devices and mobile apps to improve daily life activities. It also tests if beacon sensors can detect when patients stop using their low vision aids to prompt timely rehabilitation services.
What are the potential side effects?
Since this trial involves non-medical interventions like rehabilitation and sensor monitoring rather than drugs or invasive procedures, traditional side effects are not a concern. However, participants may experience frustration or fatigue during adaptation to the new technologies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older with vision loss from an eye condition.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I can understand and respond to study procedures and visual stimuli.
Select...
I have significant hearing loss.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 4 months, 8 months, 12 months, 13 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 4 months, 8 months, 12 months, 13 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Activity Inventory
Secondary study objectives
Adherence to hand-held optical magnifier use (frequency and duration)
Informant surveys by close acquaintances of participants
International Reading Speed Text (IReST)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telerehabilitation with low vision providerExperimental Treatment1 Intervention
Low Vision Rehabilitation for use of magnification or visual assistive devices using videoconferencing for remotely delivered follow-up care
Group II: Usual Care In-OfficeActive Control1 Intervention
Low Vision Rehabilitation in-office for use of magnification or visual assistive devices
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Vision Rehabilitation
2019
N/A
~210

Find a Location

Who is running the clinical trial?

Southern California College of Optometry at Marshall B. Ketchum UniversityOTHER
23 Previous Clinical Trials
1,107 Total Patients Enrolled
University of California, Los AngelesLead Sponsor
1,562 Previous Clinical Trials
10,262,011 Total Patients Enrolled
University of NebraskaOTHER
555 Previous Clinical Trials
1,145,034 Total Patients Enrolled
~233 spots leftby Jun 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top